GSK Fails Again To Nix Antitrust Claims Over Wellbutrin

A federal judge has foiled GlaxoSmithKline PLC's latest campaign to dismiss direct purchaser claims in a class action accusing the drugmaker of filing baseless patent suits to delay generic competition in...

Already a subscriber? Click here to view full article